Delivery Order SPE2DB22D3301-SPE2DB24FZ3JW

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $9,369.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The order is for the supply of 90 tablets of the prescription medication Candesartan Cilexetil 16 mg. The contract has a performance period ending on September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies to provide a wide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $2,277.09 and a period of performance ending on August 2, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation. This contract award is associated with a larger Indefinite Delivery Contract (IDC) between...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $35,632.27 and an ultimate completion date of October 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support military treatment facilities and other government healthcare providers. The contract is not set aside for any...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 32 mg tablets. The contract has a firm fixed price ceiling value of $9,059.79 and a period of performance extending to October 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $2,847.82 and is a firm fixed price contract with a completion date of July 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, will be delivering these prescription medications to support military treatment facilities and federal healthcare programs. The contract is not set...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Candesartan Cilexetil 16 mg tablets, a prescription medication. The contract has a ceiling value of $39,839.69 and an ultimate completion date of September 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of January 24, 2025 and a ceiling value of $15,714.20. AmerisourceBergen is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $1,635.26, is for the supply of Candesartan Cilexetil 32 mg tablets in 90-count bottles. The contract has a period of performance through November 19, 2024 and is a firm-fixed price contract. There is no indication that this contract award has a set-aside designation. The contract appears to be...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $14,410.55 firm fixed price contract is for the supply of Candesartan Cilexetil 16 MG tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and Amerisourcebergen, which provides a wide range of pharmaceutical and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,625.23 firm fixed-price contract is for the supply of 90-count bottles of 16 mg Candesartan Cilexetil tablets, a cardiovascular medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ3JW
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Candesartan Cilexetil 16 mg in 90-count bottles. The contract has a ceiling value of $3,216.60 and a period of performance that runs through August 22, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen leverages its extensive supply chain capabilities to provide critical pharmaceutical products to support military treatment facilities and other federal healthcare programs managed by the DLA.

Generated 11/20/24, 9:16 AM